CP 403 30 mg Pill - brown & white capsule/oblong, 18mm
Pill with imprint CP 403 30 mg is Brown & White, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 30 mg. It is supplied by CorePharma, LLC.
Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for CP 403 30 mg
Methylphenidate Hydrochloride Extended-Release
- Imprint
- CP 403 30 mg
- Strength
- 30 mg
- Color
- Brown & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- CorePharma, LLC
- National Drug Code (NDC)
- 64720-0403 (Discontinued)
- Inactive Ingredients
-
povidone,
hypromelloses,
polyethylene glycol,
ethylcellulose,
cetyl alcohol,
sodium lauryl sulfate,
dibutyl sebacate,
gelatin,
titanium dioxide,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,074)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
- Methylphenidate drug information
- Methylphenidate transdermal
- Methylphenidate Chewable Tablets
- Methylphenidate Controlled-Release Tablets
- Methylphenidate Extended-Release Capsules (Evening Formulation)
Other brands
Ritalin, Concerta, Jornay PM, Ritalin LA, ... +10 more
Professional resources
- Methylphenidate monograph
- Methylphenidate CD Capsules (FDA)
- Methylphenidate Chewable Tablets (FDA)
- Methylphenidate ER Capsules (FDA)
- Methylphenidate Hydrochloride (FDA)
Other brands
Ritalin, Concerta, Jornay PM, Ritalin LA, ... +10 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.